These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 4832285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Spirometry following glucagon and isoproterenol in chronic obstructive lung disease.
    Al-Naggar M, Collins VJ.
    Middle East J Anaesthesiol; 1974 Oct; 4(3):197-204. PubMed ID: 4480610
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
    Chatterjee SS, Dinda P, Riding WD.
    Scand J Respir Dis; 1971 Oct; 52(2):71-6. PubMed ID: 5170643
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC, Clément J, Van de Woestijne KP.
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the bronchodilator effects of aerosol carbuterol and isoproterenol in chronic obstructive lung disease.
    Kulpati DD, Bogra KC, Kinra V, Kamath R.
    J Assoc Physicians India; 1981 Dec; 29(12):990-7. PubMed ID: 6897242
    [No Abstract] [Full Text] [Related]

  • 7. Bronchodilatation by metered inhaler (Prenomiser) in obstructive airway disease.
    Store SD, Kamat SR, Purohit SD, Rane MA.
    J Assoc Physicians India; 1974 Jul; 22(7):515-9. PubMed ID: 4436242
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regional lung function and over-all gas exchange in chronic obstructive lung disease: the effect of intermittent positive pressure breathing with isoproterenol.
    Dawson A, Rocamora JM.
    Am Rev Respir Dis; 1974 Mar; 109(3):338-44. PubMed ID: 4592451
    [No Abstract] [Full Text] [Related]

  • 10. Bronchial component in chronic obstructive lung disease.
    Ayres SM, Griesbach SJ, Reimold F, Evans RG.
    Am J Med; 1974 Aug; 57(2):183-91. PubMed ID: 4843892
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of isoproterenol and isoproterenol-phenylephrine aerosols.
    Grant JL, Werfelman N, Cook MR, Metherall W.
    Chest; 1971 Aug; 60(2):129-32. PubMed ID: 5571471
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical results of the phenylephrine, isoprenaline, and atropine association in the treatment of obstructive respiratory insufficiency].
    Pino G, Rovera R, Cozza G.
    Minerva Med; 1972 Jan 24; 63(5):308-19. PubMed ID: 4551951
    [No Abstract] [Full Text] [Related]

  • 17. Effect of bronchodilator aerosols on single-breath ("effective") lung volumes in patients with chronic non-allergic obstructive lung disease.
    Teculescu D.
    Rev Roum Med Intern; 1972 Jan 24; 9(6):559-67. PubMed ID: 4571831
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic obstructive lung disease: postural relief of dyspnea.
    Barach AL.
    Arch Phys Med Rehabil; 1974 Nov 24; 55(11):494-504. PubMed ID: 4441261
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.